Credit Agricole
SUPN icon

Credit Agricole’s Supernus Pharmaceuticals SUPN Stock Holding History

Credit Agricole’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-6,647
Closed -$49K – 1686
2013
Q3 		$49K Buy
+6,647
New +$44.6K ﹤0.01% 1484

Other funds holding SUPN

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
OHCM
Orchard Hill Capital Management New York $22.6M AUM 3.52% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
MOACM
Mutual of America Capital Management New York $8.8B AUM 29.06% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Credit Agricole's SUPN Position: Q4 2013 in Review

Credit Agricole sold out of Supernus Pharmaceuticals (SUPN) in Q4 2013, closing a stake of 6,647 shares — an estimated $49K sold.

Credit Agricole first reported a position in SUPN in Q3 2013 and held it in 1 quarter. The position peaked at $49K in Q3 2013. 64 funds tracked by Wall St. Rank hold SUPN as of Q4 2013.

  • Credit Agricole reported no remaining Supernus Pharmaceuticals position as of Q4 2013 after selling out during the quarter.
  • Credit Agricole sold 6,647 Supernus Pharmaceuticals shares in Q4 2013, an estimated $49K.
  • Credit Agricole first reported a position in Supernus Pharmaceuticals in Q3 2013 and held it in 1 quarter.
  • Credit Agricole's Supernus Pharmaceuticals position peaked at $49K in Q3 2013.
  • 64 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2013.

Based on Credit Agricole's 13F filing for Q4 2013, filed 11 Feb 2014.